Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
55.54 Up 0.21(0.38%) 4:00PM EDT
Prev Close:55.33
Open:56.07
Bid:55.44 x 100
Ask:55.64 x 400
1y Target Est:99.00
Beta:2.28
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:54.82 - 57.12
52wk Range:45.52 - 112.57
Volume:389,330
Avg Vol (3m):867,964
Market Cap:4.20B
P/E (ttm):N/A
EPS (ttm):-5.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYUp 0.38%4.20B
MRKDown 0.85%169.73B
PFEDown 0.71%186.64B
VRXUp 1.72%42.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):113.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.94
Quarterly EPS Est (Jun-14) :-0.52
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback